Technical Analysis for LABS - Medipharm Labs Corp.

Grade Last Price % Change Price Change
grade B 6.0 0.33% 0.020
LABS closed up 0.33 percent on Friday, August 16, 2019, on 1.28 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical LABS trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.33%
Calm After Storm Range Contraction 0.33%
Wide Bands Range Expansion 0.33%
Down 3 Days in a Row Weakness 0.33%
Down 4 Days in a Row Weakness 0.33%
Gapped Down Weakness 0.33%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.23%
Calm After Storm Range Contraction -3.23%

Older signals for LABS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
MediPharm Labs, through its subsidiary, is a pioneer in the cannabis industry and has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulations (ACMPR) without first receiving a cannabis cultivation licence. This expert focus on cannabis concentrates from our cGMP (current Good Manufacturing Practices) and ISO standard clean rooms and critical environments laboratory, allows MediPharm Labs to work with its established, Health Canada-approved cultivation partners to produce pharmaceutical-grade cannabis oil with a competitive advantage. MediPharm Labs is research-driven and focused on downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. MediPharm Labs, through its subsidiary, provides B2B contract processing of cannabis to Canadian authorized licensed producers and appropriate international growers, supplying integrity-assured cannabis oil to qualified companies for sale under their own brand. In addition, MediPharm Labs will supply raw materials, formulations, processing and packaging for the creation of ready-to-sell advanced derivative products. Through its subsidiary, MediPharm Labs Australia Pty. Ltd., MediPharm Labs has also completed its application process with the federal Office of Drug Control to extract and import medical cannabis products in Australia.
Medicine Cannabis Entheogens Euphoriants Medicinal Plants Herbalism Medical Cannabis Health Sciences Cannabis In Canada Pharmaceuticals Policy Legality Of Cannabis Access To Cannabis For Medical Purposes Regulations Business To Business Licensed Producer Licensed Producers Medical Cannabis Products
Is LABS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 7.39
52 Week Low 0.91
Average Volume 836,274
200-Day Moving Average 3.6346
50-Day Moving Average 5.3244
20-Day Moving Average 5.6935
10-Day Moving Average 6.206
Average True Range 0.4765
ADX 26.88
+DI 30.226
-DI 19.7373
Chandelier Exit (Long, 3 ATRs ) 5.8505
Chandelier Exit (Short, 3 ATRs ) 5.4595
Upper Bollinger Band 7.0213
Lower Bollinger Band 4.3657
Percent B (%b) 0.62
BandWidth 46.642663
MACD Line 0.312
MACD Signal Line 0.2727
MACD Histogram 0.0393
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.525
Resistance 3 (R3) 6.567 6.433 6.438
Resistance 2 (R2) 6.433 6.300 6.413 6.408
Resistance 1 (R1) 6.217 6.217 6.150 6.175 6.379
Pivot Point 6.083 6.083 6.050 6.063 6.083
Support 1 (S1) 5.867 5.950 5.800 5.825 5.621
Support 2 (S2) 5.733 5.867 5.713 5.592
Support 3 (S3) 5.517 5.733 5.563
Support 4 (S4) 5.475